Malaria Diagnostics Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

The rapid advancement in technology and the rising demand for molecular-based diagnostics drive the market for malaria diagnosis. Furthermore, the continuously surging malaria cases and the fatalities considerably drive the market for malaria diagnosis. As per WHO, In 2020, there were an estimated 241 million cases of malaria worldwide and the estimated number of malaria deaths stood at 6,27,000 in 2020. The population groups such as infants, children under 5 years of age, pregnant women, and patients with HIV as well as people with low immunity, are at considerably higher risk of contracting malaria. Furthermore, the increasing awareness about the severity of the disease along with the government efforts contributes to the market for the malaria diagnostic.

According to UnivDatos Market Insights (UMI)’ research report “Global Malaria Diagnostics Market Analysis, 2021”, the Malaria diagnostics market is projected to grow at a CAGR of ~5% during 2021-27F.

Download Free Sample of this Report -https://univdatos.com/get-a-free-sample-form-php/?product_id=21597

Based on the technology, the market is segmented into rapid diagnostic tests (RDTs), PCR, microscopy, ELISA, and others. In 2020, the RDT segment held a significant share in the market owing to its cost efficiency, stability at higher temperatures and the provides results in a short duration. However, during the forecast period, the PCR segment is expected to witness considerable growth. This is mainly due to the increased efficiency and accuracy that can detect the specific strains of the malarial parasite. Furthermore, the increasing research on molecular diagnostic techniques is likely to have a positive impact on the segment growth in the malaria diagnostic market.

Hospital Segment to Witness Robust growth

Based on end-users, the market is segmented into hospitals, clinics, and diagnostics laboratories. The hospital segment grabbed significant market share in the malaria diagnostics market in 2020. This is mainly due to the rapidly increasing hospitalization cases due to malaria. Furthermore, the increasing geriatric population and rising prevalence of multiple diseases along with malaria among them make hospitals ideal places for them to treat multiple diseases under a single roof. 

LAMEA to Witness Explicit Growth

For a better understanding of the market adoption of the malaria diagnostics, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Latin America, Middle East & Africa (LAMEA). In 2020, the LAMEA accounted for significant growth in the global malaria diagnostic market during the forecast period. This is due to the increasing prevalence of malaria in the region. According to WHO, in past years the African region shouldered more than 90% of the malaria cases.

For more informative information, please visit us – https://univdatos.com/report/malaria-diagnostics-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Malaria Diagnostics Market include Access Bio., Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd., Sysmex Partec GmbH, bioMérieux, Beckman Coulter, Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, and Olympus Corporation, among others. The players are focused on launching products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.  

“Global Malaria Diagnostics Market Analysis, 2021” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for Malaria diagnostics providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

For more informative information, please visit us – https://univdatos.com/report/malaria-diagnostics-market/

Market Segmentation:

1.     By Technology (Rapid diagnostic tests (RDTs), PCR, Microscopy, ELISA, and Others)

2.     By End-users (Hospitals, Clinics, and Diagnostics laboratories)

3.     By Region (North America, Europe, Asia-Pacific, Rest of the World)

4.     By Company (include Access Bio., Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd., Sysmex Partec GmbH, bioMérieux, Beckman Coulter, Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, and Olympus Corporation., etc.)

Key questions answered in the study:

1.     What are the current and future trends of the malaria diagnostics industry?

2.     How the industry has been evolving in terms of technology and end-users?

3.     How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.     What are the key growth drivers and challenges for the malaria diagnostics industry?

5.     What is the customer orientation, purchase behavior, and expectations from the Malaria diagnostics firms across various regions? 

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL MALARIA DIAGNOSTICS MARKET COVID-19 IMPACT

6 GLOBAL MALARIA DIAGNOSTICS MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY TECHNOLOGY

8 MARKET INSIGHTS BY END-USERS

9 MARKET INSIGHTS BY REGION

10 MALARIA DIAGNOSTICS MARKET DYNAMICS

11 MALARIA DIAGNOSTICS MARKET OPPORTUNITIES

12 MALARIA DIAGNOSTICS MARKET TRENDS

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

17 COMPANY PROFILED

18 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·       Virtual Healthcare Delivery Market to Reach US$ 122 Billion by 2027 Globally |CAGR: 24.6%| 

·       Preventive Healthcare Technologies and Services Market to Reach US$ 493.1 Billion by 2027 Globally |CAGR: 10.5%| 

·       Internet of Medical Things Market to Reach US$ 284.5 Billion by 2027 Globally | CAGR: 18.5% |

·       Healthcare Analytics Market to Reach US$ 118.2 Billion by 2027 Globally |CAGR: 31%|